TIDMCRYO 
 
RNS Number : 0137M 
Cryo-Save Group NV 
17 May 2010 
 

17 May 2010 
 
Cryo-Save Group N.V. 
 
 
Director/PDMR Shareholding 
 
Cryo-Save Group N.V.(AIM/Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's 
leading stem cell bank, has been informed today that Mr Johan Goossens, 
Chairman, purchased 25,000 ordinary shares of Euro 0.10 ('Ordinary Shares') at 
EUR5.78 on 14 May 2010. 
 
Following this purchase, Johan Goossens is beneficially interested in 1,655,000 
ordinary shares, representing approximately 17.92% of the Company's issued share 
capital. 
 
+------------------------------------------+--------------------+ 
| Enquiries:                               |                    | 
+------------------------------------------+--------------------+ 
|                                          |                    | 
+------------------------------------------+--------------------+ 
| Cryo-Save Group                          |       +  31 (0)575 | 
|                                          |             548998 | 
+------------------------------------------+--------------------+ 
| Arnoud van Tulder, Chief Executive       |                    | 
| Officer                                  |                    | 
+------------------------------------------+--------------------+ 
| Marc Waeterschoot, Executive Director    |                    | 
+------------------------------------------+--------------------+ 
|                                          |                    | 
+------------------------------------------+--------------------+ 
| Daniel Stewart & Company plc             |   + 44 (0) 20 7776 | 
|                                          |               6550 | 
+------------------------------------------+--------------------+ 
| Simon Leathers/Emma Earl                 |                    | 
+------------------------------------------+--------------------+ 
|                                          |                    | 
+------------------------------------------+--------------------+ 
| College Hill (UK)                        |   + 44 (0) 20 7457 | 
|                                          |               2020 | 
+------------------------------------------+--------------------+ 
| Adrian Duffield/Rozi Morris              |                    | 
+------------------------------------------+--------------------+ 
|                                          |                    | 
+------------------------------------------+--------------------+ 
| SPJ Financiële Communicatie Amstelveen   | +31 (0)20 647 8181 | 
| (NL)                                     |                    | 
+------------------------------------------+--------------------+ 
| Kees Jongsma/Léon Melens                 |                    | 
+------------------------------------------+--------------------+ 
 
About Cryo-Save 
 
With more than 130,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world. Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSLIFSEELIDLII 
 

Cryo-Save (LSE:CRYO)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Cryo-Save 차트를 더 보려면 여기를 클릭.
Cryo-Save (LSE:CRYO)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Cryo-Save 차트를 더 보려면 여기를 클릭.